Fig. 7From: Platinum-based drugs induce phenotypic alterations in nucleoli and Cajal bodies in prostate cancer cellsLocalization of TDP-43 in prostate cancer cells upon platinum drug treatments. Immunofluorescence staining of TDP-43 and Coilin showing the localization response to 24 h drug treatments in the nuclei of A) LNCaP, B) PC-3, and C) 22Rv1 cells. TDP-43 (green), Coilin (red), merge of TDP-43 and Coilin (Merge RG), brightfield, DAPI, and Merge of TDP-43, Coilin and DAPI is shown. Scale bars, 5 µmBack to article page